Paper Review Records
All Paper Review Records
30 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
229
days
Blocking aryl hydrocarbon receptor remodels myeloid–T cell crosstalk and enhances anti-PD-1 response in the tumor microenvironment
Authors
Dong Kwon Kim; Sujeong Baek; Youngtaek Kim; Seung Min Yang; So Young Park; Su Jin Choi; Ju Hyeon Lee; Sang Hoon Lee; Jongho Cho; Daewon Cha; Dajeong Kim; Sunghwa Kim; Jae Hwan Kim; Byoung Chul ChoShow moreShow less
Affiliations
1. Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea; 2. Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea; 3. Yonsei New Il Han Institute for Integrative Lung Cancer Research, Yonsei University College of Medicine, Seoul, Korea; 4. Dong-A ST Research Institute, Yongin-si, Korea; 5. Division of Medical Oncology, Department of Internal Medicine, Severance Hospital, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, KoreaShow moreShow less
40
days
Oncogenic RAS as an adaptive signaling ecosystem: context-dependent vulnerabilities and resistance-informed therapeutic design
Authors
Amir Abbas Hamidi; Omeed Moaven; Reihaneh Alsadat Mahmoudian; Mohammad Reza AbbaszadeganShow moreShow less
Affiliations
1. Department of Medical Genetics and Molecular Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran; 2. Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; 3. Division of Surgical Oncology, Department of Surgery, LSU Health New Orleans School of Medicine, New Orleans, USA; 4. LSU LCMC Health Cancer Center, New Orleans, USA; 5. Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, IranShow moreShow less
92
days
Innovations and emerging trends in adoptive cell therapies for solid tumors: engineering strategies and clinical translation
Authors
Peng Huang; WenLin Wu; Yu Min; Yi Zhang; YunFeng Tao; Zheran Liu; Zhigong Wei; Xingchen PengShow moreShow less
Affiliations
1. Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, P.R. China; 2. Nuclear Physics and Medical Research Key Laboratory of Sichuan Province, Sichuan University, Chengdu, P.R. ChinaShow moreShow less
186
days
Cobimetinib impairs tumor survival and immune escape by altering my-CAFs in BRAFV600E-mutated anaplastic thyroid carcinoma
Authors
Mario Udinotti; Niclas Ramm; Thamer Abed Alhaleem Amin Hamdan; Muhammad Sameer Ali Khan; Udo Siebolts; Marcus Bauer; Kerstin Lorenz; Christine Dierks; Claudia Wickenhauser; Barbara SeligerShow moreShow less
Affiliations
1. Institute of Pathology, Section Immunopathology, Martin Luther University Halle-Wittenberg, Halle, Germany; 2. Institute of Tumor Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany; 3. Institute of Pathology, University Hospital, Cologne, Germany; 4. Department of Visceral, Vascular and Endocrine Surgery, Martin Luther University Halle-Wittenberg, Halle, Germany; 5. Department of Hematology/Oncology and Stem Cell Transplantation, KIM IV, Martin-Luther University Halle-Wittenberg, Halle, Germany; 6. Department of Hematology and Oncology, Freiburg University Medical Center, Albert-Ludwigs-University of Freiburg, Breisgau, Germany; 7. Institute of Translational Immunology, Center for Translational Medicine, Faculty of Health Sciences Brandenburg, Brandenburg Medical School Theodor Fontane, Brandenburg, Germany; 8. Fraunhofer Institute for Cell Therapy and Immunology (IZI), Leipzig, GermanyShow moreShow less
186
days
Dysregulated KMT2D mutant targeting immunogenic rewiring to overcome epigenetic entropy promotes follicular lymphomagenesis
Authors
Yuqian Zhu; Jingwei Yao; Yuelong Jiang; Qian Lai; Qinwei Chen; Jingxing Zhang; Manman Deng; Zhijuan Lin; Yiming Luo; Zhifeng Li; Long Liu; Zhong Zheng; Jie Zha; Bing XuShow moreShow less
Affiliations
1. Department of Hematology, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China; 2. Key Laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen, China; 3. Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaShow moreShow less
199
days
Multimodal AI and single-cell transcriptomics integrate to construct a histopathological prognostic model for bladder cancer, revealing the RTN3-glycolysis axis in chemoresistance
Authors
Shunli Yu; Yingjian Wang; Dapeng Feng; Xinglai Dai; Yongbo Luo; Jianing Wang; Zihe Wang; Fuxiang Chen; Haoran Wang; Fengyan Tian; Xuejia Zhai; Chaohui GuShow moreShow less
Affiliations
1. Department of Urology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; 2. Department of Endocrinology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; 3. Department of Pediatrics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; 4. Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, ChinaShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
